Spain Cell Viability Assays Market Size & Outlook

The cell viability assays market in Spain is expected to reach a projected revenue of US$ 53.6 million by 2030. A compound annual growth rate of 9.4% is expected of Spain cell viability assays market from 2024 to 2030.
Revenue, 2023 (US$M)
$28.6
Forecast, 2030 (US$M)
$53.6
CAGR, 2024 - 2030
9.4%
Report Coverage
Spain

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Spain cell viability assays market, 2018-2030 (US$M)

Spain cell viability assays market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Spain cell viability assays market highlights

  • The Spain cell viability assays market generated a revenue of USD 28.6 million in 2023 and is expected to reach USD 53.6 million by 2030.
  • The Spain market is expected to grow at a CAGR of 9.4% from 2024 to 2030.
  • In terms of segment, consumables was the largest revenue generating product in 2023.
  • Consumables is the most lucrative product segment registering the fastest growth during the forecast period.

Cell viability assays market data book summary

Market revenue in 2023USD 28.6 million
Market revenue in 2030USD 53.6 million
Growth rate9.4% (CAGR from 2024 to 2030)
Largest segmentConsumables
Fastest growing segmentConsumables
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationConsumables, Instruments
Key market players worldwideThermo Fisher Scientific Inc, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Merck KGaA, BD, PerkinElmer, Promega, Abcam PLC, Charles River Laboratories International Inc, Biotium, Creative Bioarray

Other key industry trends

  • In terms of revenue, Spain accounted for 2.0% of the global cell viability assays market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany cell viability assays market is projected to lead the regional market in terms of revenue in 2030.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 181.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Cell Viability Assays Market Companies

Name Profile # Employees HQ Website
Creative Bioarray View profile 51-100 New York, New York, United States, North America http://www.creative-bioarray.com
Biotium View profile 11-50 Fremont, California, United States, North America https://biotium.com/
Promega View profile 5001-10000 Madison, Wisconsin, United States, North America http://www.promega.com/es
PerkinElmer View profile 10001+ Waltham, Massachusetts, United States, North America http://www.perkinelmer.com
BD View profile 10001+ Franklin Lakes, New Jersey, United States, North America https://www.bd.com
Abcam PLC View profile 1760 Discovery Drive, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AX https://www.abcam.com
Charles River Laboratories International Inc View profile 21400 251 Ballardvale Street, Wilmington, MA, United States, 01887 https://www.criver.com
Bio-Rad Laboratories Inc View profile 8030 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 https://www.bio-rad.com
Agilent Technologies Inc View profile 17700 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 https://www.agilent.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Merck KGaA View profile 62345 Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 https://www.emdgroup.com

Spain cell viability assays market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell viability assays market will help companies and investors design strategic landscapes.


Consumables was the largest segment with a revenue share of 60.14% in 2023. Horizon Databook has segmented the Spain cell viability assays market based on consumables, instruments covering the revenue growth of each sub-segment from 2018 to 2030.


  • Spain Cell Viability Assays Product Outlook (Revenue, USD Million, 2018-2030)
    • Consumables
      • Microplates
      • Reagents and Assay Kits
        • Dye exclusion assays
        • Colorimetric assays
        • Fluorometric assays
        • Luminometric assays
    • Instruments
      • Spectrophotometer
      • Microscopy
      • Cell imaging and analysis system
      • Flow Cytometry
      • Others
  • Spain Cell Viability Assays Application Outlook (Revenue, USD Million, 2018-2030)
    • Drug Discovery and Development
    • Stem Cell Research
    • Diagnostics
  • Spain Cell Viability Assays End-user Outlook (Revenue, USD Million, 2018-2030)
    • Biopharmaceutical & Pharmaceutical Companies
    • CROs & CMOs
    • Academic & Research Institutes
    • Diagnostic Labs

Reasons to subscribe to Spain cell viability assays market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Spain cell viability assays market databook

  • Our clientele includes a mix of cell viability assays market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Spain cell viability assays market, including forecasts for subscribers. This country databook contains high-level insights into Spain cell viability assays market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Spain cell viability assay market report size, by product, 2018-2030 (US$M)

Spain Cell Viability Assays Market Share, 2023 & 2030 (US$M)

Spain cell viability assay market report size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online